{"nct_id":"NCT02718911","title":"A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2023-10","start_date":"2016-06-16","start_date_type":"ACTUAL","primary_completion_date":"2018-12-14","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}